Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Zoe M. Lipman"'
Autor:
Juliano Tiburcio de Freitas, Varsha Thakur, Kathryn M. LaPorte, Vijay S. Thakur, Brian Flores, Valentina Caicedo, Chioma G. E. Ajaegbu, Giuseppe Ingrasci, Zoe M. Lipman, Keman Zhang, Hong Qiu, Thomas R. Malek, Barbara Bedogni
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-14 (2024)
Abstract Background Immune checkpoint inhibitors (ICI) have dramatically improved the life expectancy of patients with metastatic melanoma. However, about half of the patient population still present resistance to these treatments. We have previously
Externí odkaz:
https://doaj.org/article/02f457d9d27b4896be22ab657b8b7584
Autor:
Leigh A. Nattkemper, Zoe M. Lipman, Giuseppe Ingrasci, Claudia Maldonado, Juan Carlos Garces, Enrique Loayza, Gil Yosipovitch
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Scalp psoriatic itch is a common, bothersome, yet understudied, condition with numerous associated treatment challenges. The aim of this study was to enhance our understanding of the pathophysiology of scalp psoriatic itch. Immunohistochemical analys
Externí odkaz:
https://doaj.org/article/fdfc0a2d0d72461b936ac95ec09fc0a7
Autor:
Zoe M. Lipman, Antonella Tosti
Publikováno v:
Allergies, Vol 1, Iss 4, Pp 225-232 (2021)
Many ingredients found within nail cosmetic products are capable of sensitizing patients’ immune systems and causing contact dermatitis (CD). These include but are not limited to tosylamide, (meth)acrylates, and formaldehyde. A clear temporal relat
Externí odkaz:
https://doaj.org/article/1f685a387273479786e6ac3b2e178d3a
Autor:
Zoe M. Lipman, BS, Nina Magnolo, MD, Rachel S. Golpanian, BA, Michael Storck, PhD, Gil Yosipovich, MD, Claudia Zeidler, MD
Publikováno v:
JAAD International, Vol 2, Iss , Pp 96-97 (2021)
Externí odkaz:
https://doaj.org/article/74eb0e7dcd064f1ba15995367c7f615b
Publikováno v:
Clinical Kidney Journal
Chronic kidney disease (CKD)-associated pruritus (CKD-aP) is an underdiagnosed yet severely distressing condition that impacts 60% of patients on dialysis and many nondialysis patients with Stages 3–5 CKD. However, despite its high prevalence, ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12964bf92ede3782f58b56ca66007c6f
http://europepmc.org/articles/PMC8702820
http://europepmc.org/articles/PMC8702820
Publikováno v:
Dermatitis. 33:249-256
Autoimmune progesterone dermatitis (AIPD) is a cyclical, cutaneous reaction to endogenous progesterone that occurs throughout the menstrual cycle. The cutaneous manifestations of AIPD vary greatly from patient to patient, ranging anywhere from urtica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c969888d4f20bb202ef264f686ce53
https://doi.org/10.1097/der.0000000000000779
https://doi.org/10.1097/der.0000000000000779
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Pruritus is the most burdensome and prevalent symptom in patients suffering from atopic dermatitis. Treating atopic itch has historically been a challenge due to multiple underlying mechanisms within its pathogenesis and an incomplete understanding o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dffe59476bc37b701855ea13402d9261
http://europepmc.org/articles/PMC8349193
http://europepmc.org/articles/PMC8349193
Publikováno v:
Medical Clinics of North America. 105:699-721
Chronic pruritus (itch lasting ≥6 weeks) is a bothersome chief complaint that may present in a broad variety of diseases. Most itch-causing diagnoses fit into 1 of 5 categories (inflammatory, secondary to systemic disease, neuropathic, chronic prur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd642eadefdd3a070abb93a792e4ff2
https://doi.org/10.1016/j.mcna.2021.04.007
https://doi.org/10.1016/j.mcna.2021.04.007
Publikováno v:
Experimental Dermatology. 30:1208-1217
While there is a vast array of aetiologies that may lead to chronic pruritus, recent data suggests that many of these conditions share similar interactions between keratinocytes, nerves, and the immune system. Specifically, the type 2 immune response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bcace4a91d8d616a502a5f6eea24a82
https://doi.org/10.1111/exd.14401
https://doi.org/10.1111/exd.14401
Publikováno v:
Expert review of clinical immunology. 17(12)
INTRODUCTION While topical medications are the first line of treatment for mild-to-moderate atopic dermatitis, they are ineffective in individuals with diffuse disease and moderate-to-severe atopic itch. For these individuals, as well as those who do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fae3bc80a8f07aa9936ecd21522f95c
https://pubmed.ncbi.nlm.nih.gov/34720031
https://pubmed.ncbi.nlm.nih.gov/34720031